preventive – Health

FDA Approves Qulipta (atogepant) Oral CGRP Receptor Antagonist for the Preventive Treatment of Migraine

[unable to retrieve full-text content]NORTH CHICAGO, Ill., Sept. 28, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Qulipta (atogepant) for the preventive treatment of episodic migraine in adults.1 Qulipta is the first… Drugs.com – New Drug Approvals

As cyber risks grow, provider preventive measures still falling short

Hospitals are ramping up spending on cybersecurity, but physician practices have scaled back their investments on protecting data. Despite all these protection efforts, healthcare data breaches likely will cost the industry as much as $ 4 billion by the end of this year, and 2020 is likely to be even worse, contends an industry research… Read More »